4D Molecular Therapeutics (FDMT) Liabilities and Shareholders Equity (2019 - 2026)
4D Molecular Therapeutics' Liabilities and Shareholders Equity came in at $492.62 million for Q2 2026, up 4.0% from $473.64 million a year earlier but down 4.0% from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, 4D Molecular Therapeutics' Liabilities and Shareholders Equity was $566.71 million, up 1.1% from FY2024.
- Liabilities and Shareholders Equity has increased in each of the last three years, with a five-year compound annual growth rate of 14.5% (FY2020 to FY2025).
- Going back by year, Liabilities and Shareholders Equity was $560.38 million in FY2024 (+64.9%), $339.89 million in FY2023 (+29.8%), $261.85 million in FY2022 (-25.9%) and $353.49 million in FY2021 (+22.6%).
- The five-year range for quarterly Liabilities and Shareholders Equity is $240.62 million (Q3 2021) to $629.88 million (Q1 2024).
- Year-over-year, Liabilities and Shareholders Equity increased in four of the last eight quarters, with growth averaging 8.1%.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q1 2024 (growth of 158.1%), and the weakest in Q3 2025 (a decline of 29.8%).
- Business Quant data shows FDMT's Liabilities and Shareholders Equity at $512.91 million (Q1 2026), $566.71 million (Q4 2025) and $423.98 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | 4D Molecular Therapeutics | 1.01 Bn | -454.35 Mn | - | 492.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 492.62 Mn |
| Mar 31, 2026 | 512.91 Mn |
| Dec 31, 2025 | 566.71 Mn |
| Sep 30, 2025 | 423.98 Mn |
| Jun 30, 2025 | 473.64 Mn |
| Mar 31, 2025 | 515.73 Mn |
| Dec 31, 2024 | 560.38 Mn |
| Sep 30, 2024 | 604.03 Mn |
| Jun 30, 2024 | 620.12 Mn |
| Mar 31, 2024 | 629.88 Mn |
| Dec 31, 2023 | 339.89 Mn |
| Sep 30, 2023 | 361.61 Mn |
| Jun 30, 2023 | 352.50 Mn |
| Mar 31, 2023 | 244.02 Mn |
| Dec 31, 2022 | 261.85 Mn |
| Sep 30, 2022 | 280.16 Mn |
| Jun 30, 2022 | 302.94 Mn |
| Mar 31, 2022 | 324.93 Mn |
| Dec 31, 2021 | 353.49 Mn |
| Sep 30, 2021 | 240.62 Mn |
API Access
4D Molecular Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();